
Veridian Healthcare Completes Acquisition of ScarScience Brand from Mitchell-Vance Laboratories
GURNEE, Ill., Sept. 18, 2026 /PRNewswire/ -- Veridian Healthcare, LLC ("Veridian"), a portfolio company of HealthEdge Investment Partners and United Western Group, is pleased to announce that it has completed the acquisition of the ScarScience brand and related assets from Mitchell-Vance Laboratories, LLC ("Mitchell-Vance").
Founded in 2008, Mitchell-Vance has extensive experience in scar treatment research and product development. ScarScience is known for its family of medical-grade silicone scar sheets and gel serums, formulated to reduce the appearance and texture of scars. Its product portfolio includes self-adhesive silicone scar sheets and topical silicone serums.
Established in 2009, Veridian Healthcare is a leader in developing, importing, and distributing health, wellness, and personal care products across retail, e-commerce, and professional healthcare markets nationwide. With a broad portfolio that includes consumer health products, home diagnostics, and remote patient monitoring solutions, Veridian serves as a trusted partner through both private-label relationships and a diverse family of proprietary brands. Veridian brings deep expertise in product sourcing and development, regulatory compliance, and technology integration to deliver innovative solutions for consumers, patients, and healthcare organizations.
"This acquisition strengthens Veridian's position in the scar and wound care category by adding a trusted scar care brand with medical-grade silicone technology to our portfolio and extending our reach into plastic surgery, dermatology, and physical therapy channels. Mitchell-Vance's expertise and ScarScience's reputation for quality are a natural fit with Veridian's distribution capabilities," said Robert Friedberg, CEO of Veridian.
"Becoming part of Veridian's portfolio creates an opportunity to bring ScarScience to a broader range of customers while staying true to the quality and values our customers have come to trust. We look forward to what Veridian's resources and reach will make possible for ScarScience," said Jessica Rowen, President of Mitchell-Vance Laboratories.
To learn more about ScarScience and Veridian, visit ScarScienceUSA.com and VeridianHealthcare.com.
SOURCE Veridian Healthcare
Share this article